T1	Pharmacological_substance 16 26	tacrolimus
N1000 	Reference T1 MeSH:D016559	tacrolimus
T2	Pharmacological_substance 79 88	ritonavir
N1001 	Reference T2 MeSH:D019438	ritonavir
T3	Pharmacological_substance 97 115	protease inhibitor
N1002 	Reference T3 MeSH:D011480	protease inhibitor
T4	Disorder 146 158	HIV-infected
N1 	Reference T4 UMLS:C0019693	HIV-infected
T5	Pharmacological_substance 298 321	immunosuppressive drugs
N1003 	Reference T5 MeSH:D007166	immunosuppressive drugs
N1004 	Reference T5 MeSH:D007166	immunosuppressive drugs
T6	Pharmacological_substance 330 340	tacrolimus
N1005 	Reference T6 MeSH:D016559	tacrolimus
T7	Pharmacological_substance 345 354	ritonavir
N1006 	Reference T7 MeSH:D019438	ritonavir
T8	Pharmacological_substance 363 388	HIV-1 protease inhibitors
T9	Disorder 578 592	HIV-1-infected
N2 	Reference T9 UMLS:C0019693	HIV-1-infected
T10	Pharmacological_substance 612 622	tacrolimus
N1007 	Reference T10 MeSH:D016559	tacrolimus
T11	Pharmacological_substance 756 765	ritonavir
N1008 	Reference T11 MeSH:D019438	ritonavir
T12	Pharmacological_substance 790 800	tacrolimus
N1009 	Reference T12 MeSH:D016559	tacrolimus
T15	Pharmacological_substance 869 879	tacrolimus
N1010 	Reference T15 MeSH:D016559	tacrolimus
T18	Disorder 1034 1049	Crohn's disease
N3 	Reference T18 UMLS:C0010346	Crohn's disease
T20	Pharmacological_substance 1133 1143	tacrolimus
N1011 	Reference T20 MeSH:D016559	tacrolimus
T21	Pharmacological_substance 1160 1170	tacrolimus
N1012 	Reference T21 MeSH:D016559	tacrolimus
T22	Pharmacological_substance 1260 1270	tacrolimus
N1013 	Reference T22 MeSH:D016559	tacrolimus
T24	Pharmacological_substance 1360 1370	tacrolimus
N1014 	Reference T24 MeSH:D016559	tacrolimus
T25	Pharmacological_substance 1406 1413	PI drug
T26	Pharmacological_substance 1457 1467	tacrolimus
N1015 	Reference T26 MeSH:D016559	tacrolimus
T27	Pharmacological_substance 119 130	raltegravir
N1016 	Reference T27 MeSH:D000068898	raltegravir
T28	Disorder 52 57	HIV-1
N4 	Reference T28 UMLS:C0019693	HIV-1
T31	Pharmacological_substance 416 426	raltegravi
N1017 	Reference T31 MeSH:D000068898	raltegravi
T32	Subject 725 744	Three OLTX patients
T33	Subject 986 1004	two other patients
T14	Pharmacological_substance 1441 1452	raltegravir
N1018 	Reference T14 MeSH:D000068898	raltegravir
T19	Combination 1422 1433	Concomitant
T34	Combination 89 96	boosted
T35	Subject 159 167	patients
T36	Pharmacological_substance 390 393	PIs
N1019 	Reference T36 MeSH:D011480	PIs
T37	Combination 355 362	boosted
T17	Subject 1006 1020	one after OLTX
T39	Subject 1025 1028	one
T16	Pharmacological_substance 774 776	PI
N1020 	Reference T16 MeSH:D011480	PI
T40	Pharmacological_substance 1054 1065	raltegravir
N1021 	Reference T40 MeSH:D000068898	raltegravir
T42	Pharmacological_substance 1330 1332	PI
N1022 	Reference T42 MeSH:D011480	PI
T44	Subject 593 601	patients
T51	Negation_cue 1477 1479	no
T29	Combination 1096 1101	while
